Medline Inc.
MDLNNASDAQHealthcare● Active
$33.51
$-0.11(-0.31%)
Market Cap$28.3B
P/E Ratio—
52W High$50.876
52W Low$32.815
Medline Inc.（MDLN）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDLN · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $28.43B | $25.51B | $23.23B | $21.45B |
| Cost of Revenue | $20.91B | $19.22B | $18.01B | $16.89B |
| Gross Profit | $7.52B | $6.29B | $5.22B | $4.56B |
| Gross Margin %(computed) | 26.44% | 24.66% | 22.48% | 21.25% |
| Operating Expenses | ||||
| R&D Expenses | $0.00B | $0.07B | $0.06B | $0.06B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $5.31B | $4.07B | $3.78B | $3.69B |
| Operating Income | $2.21B | $2.23B | $1.44B | $0.87B |
| Operating Margin %(computed) | 7.78% | 8.72% | 6.22% | 4.06% |
| Interest Income | $0.00B | $0.28B | $0.24B | $0.03B |
| Interest Expense | $0.00B | $1.31B | $1.38B | $0.91B |
| Income Before Tax | $1.25B | $1.25B | $0.26B | $0.01B |
| Income Tax Expense | $0.09B | $0.05B | $0.03B | $0.04B |
| Net Income | $1.16B | $1.20B | $0.23B | ($0.03B) |
| Net Margin %(computed) | 4.08% | 4.70% | 1.01% | -0.12% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $1.43 | $1.52 | $0.30 | $-0.03 |
| Wtd Avg Shares | 0.81B | 0.79B | 0.79B | 0.79B |
| EBITDA | $2.92B | $3.53B | $2.59B | $1.85B |
| EBITDA Margin %(computed) | 10.26% | 13.85% | 11.15% | 8.64% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Medline Inc.
关于Medline Inc.（MDLN）损益表
Medline Inc.（MDLN）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，MDLN实现营收$28.43B，毛利润$7.52B（毛利率26.44%），净利润$1.16B（净利率4.08%）。
常见问题
MDLN · 4 问Medline Inc.（MDLN）2025财年营收为$28.43B，同比up11.5%。
MDLN revenueMDLN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08